PDF file       product list       search       home page       email       legal notice    

ABX  advanced biochemical compounds   

Product Order number / Unit

9772 DOTA-TATE acetate (GMP) 9772.0000.05: 50 μg per vial
9772.0000.10: 100 μg per vial
9772.0000.25: 250 μg per vial
9772.0000.40: 400 μg per vial
9772.0001: 1 mg per vial
Please inquire for customized filling and bulk quantities.

Precursor for radiolabelled DOTA-[Tyr3]octreotate
Manufactured according to GMP requirements for APIs
for use in clinical trials (ICH Q7 chapter 19)
Sold under license for patent EP1872800
Molar Mass: 1435.63
Colourless to off-white solid packaged in clear glass vials with inner cone and crimp cap (9772.0000.05, 9772.0000.10, 9772.0000.25 and 9772.0000.40) or dark glass screw cap vials. (9772.0001)
Purity: > 97 % (9772.0001)
> 95 % (9772.0000.05, 9772.0000.10, 9772.0000.25 and 9772.0000.40)
CoA with MS (identity); HPLC (purity); GC (residual solvents, acetate content, water content)
Chemical Name:
CA index name: CN L-Threonine, N-[[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-threonyl-L-cysteinyl-, cyclic (2→7)-disulfide, acetate (salt)
DOTA-[Tyr3]-Octreotate, DOTA-[Tyr3, Thr8]-Octreotide
Same as product number 9770.
date of product catalogue issue: 24 February 2015


  PDF file       product list       home page       search       email       legal notice